Evidence map›Paper›PMID 40102624›Full record

ArticleScientific reports2025

Limitations of estimating antibiotic resistance using German hospital consumption data - a comprehensive computational analysis.

Michael Rank, Anna Kather, Dominik Wilke, Michaela Steib-Bauert, Winfried V Kern, Ingo Röder, Katja de With

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael RankCarl Gustav Carus Faculty of Medicine, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany. Michael.rank@tu-dresden.de.ORCID http://orcid.org/0009-0009-5367-7932
Anna KatherDivision of Infectious Diseases, University Hospital Carl Gustav Carus Dresden at the TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.ORCID http://orcid.org/0000-0001-6471-6487
Dominik WilkeDivision of Infectious Diseases, University Hospital Carl Gustav Carus Dresden at the TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Michaela Steib-BauertDivision of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University Medical Centre Freiburg, University of Freiburg, Freiburg i.Br, Germany.
Winfried V KernDivision of Infectious Diseases, Department of Medicine II, Faculty of Medicine, University Medical Centre Freiburg, University of Freiburg, Freiburg i.Br, Germany.
Ingo RöderCarl Gustav Carus Faculty of Medicine, Institute for Medical Informatics and Biometry, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Katja de WithDivision of Infectious Diseases, University Hospital Carl Gustav Carus Dresden at the TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.ORCID http://orcid.org/0000-0001-9473-3018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For almost a century, antibiotics have played an important role in the treatment of infectious diseases. However, the efficacy of these very drugs is now threatened by the development of resistances, which pose major challenges to medical professionals and decision-makers. Thereby, the consumption of antibiotics in hospitals is an important driver that can be targeted directly. To illuminate the relation between consumption and resistance depicts a very important step in this procedure. With the help of comprehensive ecological and clinical data, we applied a variety of different computational approaches ranging from classical linear regression to artificial neural networks to analyze antibiotic resistance in Germany. These mathematical and statistical models demonstrate that the amount and particularly the structure of currently available data sets lead to contradictory results and do, therefore, not allow for profound conclusions. More effort and attention on both data collection and distribution is necessary to overcome this problem. In particular, our results suggest that at least monthly or quarterly antibiotic use and resistance data at the department and ward level for each hospital (including application route and type of specimen) are needed to reliably determine the extent to which antibiotic consumption influences resistance development.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, MicrobialHospitalsGermanyHumansNeural Networks, ComputerAnti-Bacterial AgentsAcute care hospitalAntibiotic consumptionAntibiotic resistanceAntimicrobial stewardshipComputational modellingMachine learning

Identifiers

PMID40102624
PMCPMC11920034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.